{
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 78
  },
  "verification_results": [
    {
      "claim": "Flublok is approved for use in persons 18 years of age and older.",
      "verdict": "supports",
      "confidence": 1.0,
      "success": true,
      "reasoning_steps": [
        {
          "id": 1,
          "reasoning": "This quote directly states the approved age range for Flublok, confirming it is approved for use in persons 18 years of age and older.",
          "quote": "Flublok is approved for use in persons 18 years of age and older. (1)",
          "start": 1120,
          "end": 1189
        }
      ]
    },
    {
      "claim": "Flublok is approved for use in children under 12 years old.",
      "verdict": "insufficient",
      "confidence": 0.0,
      "success": false,
      "reasoning_steps": [],
      "error": "Quote not found: Data froma randomized, controlled trial demonstrated that children 6 months to less than years of age had diminished hemagglutinin inhibition (HI) responses to Flublok compared to a U.S.-licensed in\ufb02uenza vaccine approved for use in this population, strongly suggesting that Flublok would not be effective in children younger than 3 years of age (6). Safety and effectiveness of Flublok have not been established in children 3 years to less than 18 years of age."
    },
    {
      "claim": "The most common side effect of Flublok is injection site pain.",
      "verdict": "insufficient",
      "confidence": 0.0,
      "success": false,
      "reasoning_steps": [],
      "error": "Quote not found: In adults 18 through 49 years of age, the most common (\u226510%) injection-site adverse reaction was pain (37%); the most common (\u226510%) solicited systemic adverse reactions were headache (15%), fatigue (15%) and muscle pain (11%). (6.1)"
    },
    {
      "claim": "Flublok contains egg proteins.",
      "verdict": "does_not_support",
      "confidence": 1.0,
      "success": true,
      "reasoning_steps": [
        {
          "id": 1,
          "reasoning": "This quote directly addresses the presence of egg proteins in Flublok, stating that it contains none. This is directly relevant to the claim.",
          "quote": "Flublok contains no egg proteins, antibiotics, or preservatives.",
          "start": 16950,
          "end": 17014
        }
      ]
    },
    {
      "claim": "Guillain-Barr\u00e9 syndrome history requires careful consideration before giving Flublok.",
      "verdict": "insufficient",
      "confidence": 0.0,
      "success": false,
      "reasoning_steps": [],
      "error": "Quote not found: If Guillain-Barr\u00e9 syndrome has occurred within 6 weeks of receipt of a prior in\ufb02uenza vaccine, the decision to give Flublok should be based on careful consideration of potential bene\ufb01ts and risks. (5.2)"
    },
    {
      "claim": "Flublok is a recombinant influenza vaccine.",
      "verdict": "insufficient",
      "confidence": 0.0,
      "success": false,
      "reasoning_steps": [],
      "error": "Quote not found: Flublok [In\ufb02uenza Vaccine] is a sterile, clear, colorless injection containing recombinant hemagglutinin(HA) proteins from three in\ufb02uenza viruses for intramuscular use."
    }
  ],
  "summary": {
    "total_claims": 6,
    "verified_claims": 2,
    "supporting_claims": 1,
    "contradicting_claims": 1,
    "insufficient_evidence": 4,
    "errors": 0
  },
  "visual_elements": [],
  "model_used": "gpt-4.1"
}